Epidemiology, Mechanisms, and Treatment of Sarcopenia and Associated Metabolic Diseases
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Endocrinology".
Deadline for manuscript submissions: closed (15 May 2023) | Viewed by 2353
Special Issue Editors
Interests: tissue engineering; biomaterials; stem cells; regenerative medicine; osteoarthritis; sarcopenia
Interests: sports training; biomedicine; materials
Special Issue Information
Dear Colleagues,
Sarcopenia is a progressive, widespread skeletal muscle disorder associated with an increased likelihood of adverse outcomes such as falls, fractures, physical disability, and death. Sarcopenia is associated with several metabolic diseases including obesity, hypertension, diabetes, etc. and it has similarities in pathogenesis (insulin resistance mainly) and its treatment (exercise, nutrition, drugs, etc.). When different criteria are used to define sarcopenia, there is a large variation in the reported prevalence between studies or even within studies, so the prevalence of sarcopenia is difficult to compare. But with the release of the consensus of the individual sarcopenia working groups, an increasing number of studies use established definitions, which allows some comparison of the prevalence across different studies. With the aging of the population, sarcopenia has become an increasingly serious health problem, which has been highly concerned by the country and the people. Paying attention to the early screening and prevention of sarcopenia in the elderly can improve the quality of life of the elderly and reduce the burden of society and families.
This research topic aims to highlight the sarcopenia and its associated metabolic diseases in a cross-over study. We specifcally focus on pathogenesis, pathological pathogenic changes, and its epidemiology. Additionally, we will reflect on exercise, nutrition, pharmacotherapy and other interventions to sarcopenia in aging and comorbidities.
This Research Topic welcomes submissions ranging from Original, Clinical, and Translational articles and Reviews in the field of Sarcopenia and Associated Metabolic Diseases.
Dr. Yusheng Li
Prof. Dr. Yuxiang Wu
Prof. Dr. Xiuhua Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcopenia
- epidemiology
- mechanisms
- treatment
- metabolic diseases
- muscle
- burden
- aging
